Transient osteoporosis of the hip: successful response to deflazacort.
Transient osteoporosis of the hip (TOH) is an uncommon condition with a poorly defined aetiology. Despite its benign prognosis, its long clinical course causes a prolonged period of functional disability in middle-aged patients. We describe two patients with TOH who showed a rapid response to deflazacort, a bone-sparing corticoid. Deflazacort may become a useful tool to shorten the otherwise lengthy recovery period of TOH.
Carmona-Ortells
L
L
Rheumatology Department, Hospital de La Princesa, Madrid, Spain.
Carvajal-Méndez
I
I
García-Vadillo
J A
JA
Alvaro-Gracia
J M
JM
González-Alvaro
I
I
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006621:Hip Joint / Q000187:drug effects; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy*; D011282:Pregnenediones / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; C021988:deflazacort